STAT January 12, 2025
In pre-JPM interview, Viehbacher says rare disease, immunology, and neurology are of interest
SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially troubled partner...